US2020316333A1PendingUtilityA1
Single Treatment Disposable Nitric Oxide Delivery
Est. expiryJan 31, 2039(~12.5 yrs left)· nominal 20-yr term from priority
A61M 2205/583A61M 16/125A61M 2202/0275A61M 2016/003A61M 2016/0027A61M 2205/3331A61M 16/208A61M 16/06A61M 2205/7545
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A therapeutic level medical gas delivery system includes a pressure regulator with a control point for a flow of medical gas through a critical flow orifice; a variable flow restrictor; and a mixing chamber for the combination of fixed flows.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A therapeutic level medical gas delivery system, comprising:
a pressure regulator with a control point for a flow of medical gas through a critical flow orifice; a variable flow restrictor; and a mixing chamber for the combination of fixed air flows.
2 . A system according to claim 1 , comprising a vessel loaded with the medical gas at a pressure greater than atmospheric.
3 . A system according to claim 2 , wherein a vessel size and a vessel pressure control a quantity of medical gas available for patient treatment.
4 . A system according to claim 2 , wherein the pressure is dependent on a stability of the gas under pressure.
5 . A system according to claim 2 , wherein the vessel is coupled to a pressure regulator that controls an outlet pressure of the medical gas.
6 . A system according to claim 5 , wherein the pressure regulator is a diaphragm, wherein the diaphragm and materials that contact the medical gas are of a material without chemical, catalytic or absorptive interaction.
7 . A system according to claim 5 , wherein the pressure regulator is set to a pressure that maintains a flow rate of the gas through the critical flow orifice at a desired therapeutic level.
8 . A system according to claim 1 , wherein the critical flow orifice provides a critical flow of nitric oxide gas when the gas reaches sonic condition.
9 . A system according to claim 1 , wherein an orifice gas flow comprises an absolute pressure ratio of about 0.5, 0.52, 0.528, or 0.53.
10 . A system according to claim 1 , wherein an orifice downstream absolute pressure (P 2 ) is approximately 52.8 per cent of an upstream absolute pressure (P 1 ).
11 . A system according to claim 1 , wherein a gas velocity of the gas through the orifice remains constant as the ratio becomes smaller while a mass flow rate is increased.
12 . A system according to claim 1 , wherein an orifice pressure into the orifice at a fixed value is maintained to create a constant mass flow of a nitric oxide gas.
13 . A system according to claim 1 , wherein the mixing chamber dilutes a fixed mass flow rate to a specified therapeutic level using patient inhalations.
14 . A method of delivering medical gases at therapeutic levels to patients comprising:
providing a vessel that contains nitric oxide at a specified pressure; controlling the pressure for controlled mass flow through a critical flow orifice; controlling the air dilution flow via patient inhalation controlled by a variable restrictor; and maintaining concentration of medical gas through mixing of two fixed mass flows.
15 . A method according to claim 14 , comprising a vessel initially loaded with the medical gas at a pressure greater than atmospheric.
16 . A method according to claim 15 , wherein a vessel size and a vessel pressure control a quantity of medical gas available for patient treatment.
17 . A method according to claim 15 , wherein the pressure is dependent on a stability of the gas under pressure.
18 . A method according to claim 15 , wherein the vessel is coupled to a pressure regulator that controls an outlet pressure of the medical gas.
19 . A method according to claim 18 , wherein the pressure regulator is a diaphragm, wherein the diaphragm and materials that contact the medical gas are of a material without chemical, catalytic or absorptive interaction.
20 . A method according to claim 18 , wherein the pressure regulator is set to a pressure that maintains a flow rate of the gas through the critical flow orifice at a desired therapeutic level. And wherein the critical flow orifice provides a critical flow of nitric oxide gas when the gas reaches sonic condition.Join the waitlist — get patent alerts
Track US2020316333A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.